Comparison of content of FDA letters not approving applications for new drugs and associated public announcements from sponsors: cross sectional study. (Record no. 24971132)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01318 a2200361 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517034946.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201508s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1756-1833 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1136/bmj.h2758 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Lurie, Peter |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150818 |
245 00 - TITLE STATEMENT | |
Title | Comparison of content of FDA letters not approving applications for new drugs and associated public announcements from sponsors: cross sectional study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | BMJ (Clinical research ed.) |
Date of publication, distribution, etc. | Jun 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | h2758 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Consumer Product Safety |
General subdivision | legislation & jurisprudence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Correspondence as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cross-Sectional Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Approval |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Industry |
General subdivision | legislation & jurisprudence |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Research Report |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | United States |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | United States Food and Drug Administration |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chahal, Harinder S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sigelman, Daniel W |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stacy, Sylvie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sclar, Joshua |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ddamulira, Barbara |
773 0# - HOST ITEM ENTRY | |
Title | BMJ (Clinical research ed.) |
Related parts | vol. 350 |
-- | p. h2758 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1136/bmj.h2758">https://doi.org/10.1136/bmj.h2758</a> |
Public note | Available from publisher's website |
No items available.